Global X Management Company’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$723K Sell
6,579
-215
-3% -$22.4K 0.01% 583
2018
Q1
$681K Buy
6,794
+34
+0.5% +$3.48K 0.01% 547
2017
Q4
$666K Sell
6,760
-462
-6% -$43.8K 0.02% 478
2017
Q3
$676K Buy
7,222
+977
+16% +$104K 0.02% 453
2017
Q2
$694K Sell
6,245
-773
-11% -$81.7K 0.02% 424
2017
Q1
$689K Buy
7,018
+836
+14% +$79.7K 0.02% 394
2016
Q4
$568K Sell
6,182
-433
-7% -$37.3K 0.03% 361
2016
Q3
$560K Buy
6,615
+2,365
+56% +$199K 0.02% 326
2016
Q2
$346K Buy
4,250
+2,211
+108% +$168K 0.02% 304
2016
Q1
$146K Buy
2,039
+1,804
+768% +$121K 0.01% 357
2015
Q4
$17K Hold
235
﹤0.01% 520
2015
Q3
$14K Buy
235
+9
+4% +$629 ﹤0.01% 534
2015
Q2
$16K Buy
+226
New +$16.7K ﹤0.01% 506

Other funds holding DGX

Global X Management Company's DGX Position: Q2 2018 in Review

Global X Management Company reduced its Quest Diagnostics (DGX) stake by 3.2% in Q2 2018, selling an estimated $22.4K and leaving 6,579 shares worth $723K. The position accounts for 0.01% of the portfolio, ranked #583.

Global X Management Company first reported a position in DGX in Q2 2015 and has held it in 13 quarters since. 662 funds tracked by Wall St. Rank hold DGX as of Q2 2018.

  • Global X Management Company held 6,579 shares of Quest Diagnostics worth $723K as of Q2 2018.
  • Global X Management Company sold 215 Quest Diagnostics shares in Q2 2018, an estimated $22.4K.
  • Quest Diagnostics made up 0.01% of Global X Management Company's portfolio in Q2 2018, its #583 holding.
  • Global X Management Company first reported a position in Quest Diagnostics in Q2 2015 and has held it in 13 quarters since.
  • 662 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.